Innominds introduces deeptech-driven solution to combat antimicrobial resistance

Some 8,000 patients suspected of Urinary Tract Infection were part of the initial series of AMR tests conducted.

Published - June 07, 2024 12:45 pm IST - Bengaluru

Innominds, a U.S.-based digital transformation and product engineering company, in partnership with Hyderabad-based SCIINV Biosciences introduced AMRx, an advanced AI/ML-driven digital diagnostic tool designed to combat the growing threat of antimicrobial resistance (AMR).

The tool would revolutionise the detection and treatment of antibiotic-resistant infections without the need for traditional cultures. It was a culture-free companion diagnostic tool that utilises AI/ML to predict Urinary Tract Infections (UTIs) and determine antibiotic resistance patterns based on patient clinical history, said the company.

‘’Traditional methods are falling short in the race against wildfire-like proliferation of Antimicrobial Resistance. It’s imperative to harness advanced digital technologies (AI/ML/DL) to develop alternative diagnostic tools and therapeutic solutions,’‘ said Prof Ranga Reddy Burri, Advisor, SCIINV Biosciences, and President, Infection Control Academy of India.

Some 8,000 patients (from seven tertiary care hospitals) suspected of Urinary Tract Infection (UTI) were part of the initial series of AMR tests conducted. The tool can capture 170 clinical parameters of a patient’s clinical history, presenting symptoms and current complaints.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.